Cargando…
Urinary biomarker discovery in gliomas using mass spectrometry-based clinical proteomics
BACKGROUND: Gliomas are the most common primary malignant brain tumors and have a poor prognosis. Early detection of gliomas is crucial to improve patient outcomes. Urine accumulates systematic body changes and thus serves as an excellent early biomarker source. METHODS: At the biomarker discovery p...
Autores principales: | Wu, Jianqiang, Zhang, Jun, Wei, Jing, Zhao, Yuanli, Gao, Youhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398313/ https://www.ncbi.nlm.nih.gov/pubmed/32922940 http://dx.doi.org/10.1186/s41016-020-00190-5 |
Ejemplares similares
-
Urinary candidate biomarker discovery in a rat unilateral ureteral obstruction model
por: Yuan, Yuan, et al.
Publicado: (2015) -
Label-Free Liquid Chromatography–Mass Spectrometry Proteomic Analysis of the Urinary Proteome for Measuring the Escitalopram Treatment Response From Major Depressive Disorder
por: Huan, Yuhang, et al.
Publicado: (2021) -
Proteomics and Mass Spectrometry for Cancer Biomarker Discovery
por: Lu, Ming, et al.
Publicado: (2007) -
Early urinary candidate biomarkers and clinical outcomes of intervention in a rat model of experimental autoimmune encephalomyelitis
por: Zhao, Mindi, et al.
Publicado: (2023) -
Mass spectrometry‐based tear proteomics for noninvasive biomarker discovery
por: Ponzini, Erika, et al.
Publicado: (2021)